Clinical Trials Browser

Esophageal Neoplasms

Rectal Neoplasms

Biliary Tract Neoplasms

Gastroesophageal Adenocarcinoma

Rectal Neoplasms

Neoplasm Metastasis, Stomach Neoplasms

Colorectal Cancer Metastatic

Colorectal Neoplasms

Colorectal Neoplasms

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Colonic Neoplasms, Rectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Carcinoma, Hepatocellular

Locally Advanced Colorectal Carcinoma

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Colonic Neoplasms, Neoplasms

Biliary Tract Neoplasms, Cholangiocarcinoma

Gastroesophageal Junction Adenocarcinoma

Colorectal Neoplasms

Carcinoma, Hepatocellular

Stomach Neoplasms

Rectal Neoplasms

Locally Advanced Rectal Cancer

Carcinoma, Hepatocellular

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Cancer With Liver Metastasis

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Locally Advanced Pancreatic Carcinoma(LAPC)

Biliary Tract Neoplasms

Rectal Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Stomach Neoplasms

Rectal Neoplasms

Oligometastatic Gastric Adenocarcinoma

Colorectal Neoplasms

Hyperthermia, Rectal Neoplasms

Gastrointestinal Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence, Colorectal Neoplasms

Colonic Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Advanced Rectal Cancer

Colonic Neoplasms, Neoplasm, Residual

Biliary Tract Neoplasms

Colorectal Neoplasms

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Recurrence

Clinical Trials

PROTECT

MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer

HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

FOBEAR

CIME

Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis

ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer

Intensified Chemotherapy in CRC After Resection of Liver Metastases

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma

JAB-21822 Combined With Chemotherapy and Bevacizumab in Second-line KRAS G12C CRC

NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer

Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.

Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer

GRACIE

FOXHIPECT4

RADIOPAN

IROCAS

SEVILLA

Folfox+Irinotecan+Chemort In Esophageal Cancer

LIVERPEARL

Systemic Chemotherapy With FOLFOX Plus Atezolizumab & Bevacizumab for Patients With Advanced HCC Who Previously Received Atezolizumab & Bevacizumab

BIG

PANTHER

CinClare-2

ICT-HCC

SAMCO

OPTIPRIME

Hypo-OPRA

COSENSE-1

A Prospective Multicenter Study: Ivosimab + Chemotherapy as Neoadjuvant for Resectable pMMR/MSS CRC Liver Mets

SED-RO-ICC

Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma:

Oncolytic Virus H101 Combined With Lenvatinib Plus Toripalimab Compared With FOLFOX in Patients With Advanced Biliary Tract Cancer (OPTIONS-06)

Organ Preservation in Early Rectal Cancer Patients

Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer

Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer

Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer

PIPAC_VEROne

Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer

ARO 2024-13

FUDOSE

Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer

REPROGRAM-02

Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer

CLAUDIA

Anlotinib Plus Nab-Paclitaxels and S-1 for Patients with Advanced Biliary Tract Cancer As Second-Line Treatment

Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer

LOGICAN